期刊文献+

乳腺癌与乳腺癌复发患者VEGF及Nm23的表达及临床意义 被引量:5

Expressions and clinical significance of VEGF and nm23 in breast cancer patients and recurrent breast cancer patients
原文传递
导出
摘要 目的:探讨乳腺癌患者和复发患者血管内皮生长因子VEGF、转移抑制基因nm23的表达及其与乳腺癌发生和复发的关系。方法:选择河北省人民医院2001年1月~2012年12月行手术治疗的乳腺癌患者和复发患者,其中乳腺癌患者38例,乳腺癌胸壁复发患者22例,用免疫组化S-P法检测正常乳腺组织、原发灶和复发灶VEGF、nm23的表达。结果:1乳腺癌复发患者癌灶VEGF的表达与乳腺癌患者无统计学差异(P〉0.05),但明显高于正常乳腺组织(P=0.000)。乳腺癌复发患者癌灶nm23的表达明显低于正常乳腺组织(P=0.000)。2淋巴结转移组VEGF明显高于无淋巴结转移组(χ2=8.866,P=0.003);淋巴结转移组nm23明显低于无淋巴结转移组(χ2=6.127,P=0.012)。3VEGF、nm23的表达呈负相关(r=-0.536,P=0.000)。结论:1VEGF、nm23与乳腺癌发生、复发、淋巴结转移密切相关;2nm23可能抑制VEGF的表达,两者在乳腺癌发生、复发、淋巴结转移中起拮抗作用。 Objective: To explore the expressions of vascular endothelial growth factor (VEGF) and nm23 in breast cancer patients and recurrent breast cancer patients and their relationships with oncogenesis and recurrence of breast cancer. Methods : A total of 38 breast cancer patients and 22 recurrent breast cancer patients treated by surgery in the hospital from January 2001 to December 2012 were selected, immunohistochemical SP method was used to detect the expressions of VEGF and ran23 in normal breast tissue, primary breast cancer lesion and recurrent breast cancer lesion. Results : There was no statistically significant difference in the expression level of VEGF between primary breast cancer lesion and recurrent breast cancer lesion ( P 〉 0. 05 ), but the expressions of VEGF in primary breast cancer lesion and recur- rent breast cancer lesion were statistically significantly higher than that in normal breast tissue (P = 0. 000) . The expression of nm23 in re- current breast cancer lesion was statistically significantly lower than that in normal breast tissue ( P = 0. 000) . The expression of VEGF in lymph node metastasis group was statistically significantly higher than that in non - lymph node metastasis group (X2 = 8. 866, P = 0. 003 ) ; the expression of nm23 in lymph node metastasis group was statistically significantly lower than that in non - lymph node metastasis group (X2 = 6. 127, P = 0. 012) . There was a negative correlation between VEGF expression and nm23 expression (r = -0. 536, P = 0. 000) . Conclusion: VEGF and nm23 are closely related to oncogenesis, recurrence and lymph node metastasis of breast cancer; nm23 may inhibit VEGF expression, VEGF and nm23 play antagonistic effects in oncogenesis, recurrence and lymph node metastasis of breast cancer.
出处 《中国妇幼保健》 CAS 北大核心 2014年第30期4983-4985,共3页 Maternal and Child Health Care of China
基金 河北省卫生厅重点课题〔20090224〕
关键词 乳腺癌 复发乳腺癌 血管内皮生长因子 转移抑制基因NM23 Breast cancer Recurrent breast cancer Vascular endothelial growth factor nm23
  • 相关文献

参考文献5

  • 1Folkman J.Angiogenesis[J].Annu Rev Med,2006,57:1-18.
  • 2雷杰,费建东,刘振显,薄爱华,张晓丽,赵英.乳腺癌组织中Ang-2及VEGF的表达及意义[J].肿瘤防治研究,2008,35(4):263-265. 被引量:7
  • 3Seeger H,Wallwiener D,Kraemer E,et al.Comparison of possible carcinogenic estradiol metabolites:effects on proliferation,apoptosis and metastasis of human breast cancer cells[J].Maturitas,2006,54(1):72-77.
  • 4Boissan M,De Wever O,Lizarraga F,et al.Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells[J].Cancer Res,2010,70(19):7710-7722.
  • 5Lavalle GE,Bertagnolli AC,Tavares WL,et al.Cox-2 expression in canine mammary carcinomas:correlation with angiogenesis and overall survival[J].Vet Pathol,2009,46(6):1275-1280.

二级参考文献14

  • 1李国灏,杨为民.血管生成素的作用、表达及其与肿瘤血管生长的关系[J].临床外科杂志,2004,12(5):311-313. 被引量:5
  • 2高冬玲,郭克民,张岚,张红新,张云汉.人乳癌组织中血管生成素-2及其受体Tie-2的表达[J].郑州大学学报(医学版),2006,41(3):517-519. 被引量:5
  • 3Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation[J]. Nature,2000, 407 (6801) : 242-248.
  • 4Peter CM, Chitra S, Pamel FJ, et al. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis[J]. Science, 1997,277(5322) : 55-60.
  • 5Toi M , Matsumoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications [J]. Lancet Oncol,2001,2(11 ) :667-673.
  • 6Caine GJ, Blann AD, Stonelake PS,et al. Plasma angiopoietin- 1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1 [J]. Eur J Clin Invest, 2003, 33(10): 883-890.
  • 7Obermair A, Kucera E, Mayerhofer K,et al. Vascular endothelial growth factor(VEGF) in human breast cancer: correlation with disease-free survival[J]. Int J Cancer, 1997,74(4): 455-458.
  • 8Sfiligoi C, de Luca A, Cascone I, et al. Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival[J]. Int J Cancer, 2003,103(4):466-474.
  • 9Wang J, Wu K, Zhang D, et al. Expressions and clinical significances of angiopoietin-1, -2 and Tie2 in human gastric cancer[J]. Biochem Biophys Res Commun, 2005, 337 ( 1 ):386- 393.
  • 10Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer[J]. Oncologist, 2000, 5 (Suppl 1 ) : 37- 44.

共引文献6

同被引文献40

  • 1邓洪新,魏于全.肿瘤基因治疗的研究现状和展望[J].中国肿瘤生物治疗杂志,2015,22(2):170-176. 被引量:26
  • 2崔曙,唐铁龙,李响,李虹.nm23-H1基因转染对膀胱癌T-24细胞转移能力及化疗敏感性的影响[J].四川大学学报(医学版),2007,38(5):788-791. 被引量:2
  • 3Steeg PS, Bevilacqua G, Sobei ME, et al. Evidence for anovel gene associated with low tumor metastastic potential[J]. J Natl Cancer Inst,1988,80(3) :200-204.
  • 4Sadek CM, Jimenex A, Damdimopoulos AE, et al. Characterization of human thioredoximlike 2 : a novel microtubule-binding thioredoxin expressed predominantly in the cilia of lung airway epithelium and spermatid manchette and axoneme[J]. J Biol Chem,2003,278(15) :13133-13142.
  • 5Dai ZL, Xiao W, Jin Y. Inhibition of nm23-h1 gene expression in chronic myelogenous leukemia cells[J]. Oncol Lett, 2013,6 (4) : 1093-1097.
  • 6苏娟娟,曲丽娟,五一曼.大肠癌转移相关基因DR-nm23功能初步研究[J].福建:福建中医药大学学报,2011,26(5):304-307.
  • 7Lee MJ, Xu DY, Li H, et al. Pro-oncogenic potential of NM23 H2 in hatoeellular careinoma[J]. Exp Mol Med,2012, 44(3) :214-224.
  • 8Boissan M, De Wever O, Lizarraga F, et al. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells[J]. Cancer Res,2010,70(19) :7710-7722.
  • 9Izano MA, Fung TT, Chiuve SS, et al. Are diet quality scores after breast cancer diagnosis associated with im- proved breast cancer survival[-J. Nutr Cancer, 2013,65 (6) :820-826.
  • 10Dumalaon-Canaria JA, Hutchinson AD,Prichard I, et al.What causes breast cancer A systematic review of causal attributions among breast cancer survivors and how these compare to expert endorsed risk factors[J]. Cancer Cau- ses Control,2014,25(7) :771- 785.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部